Group 2 innate lymphoid cells in health and disease

Cold Spring Harbor Perspectives in Biology

Volumn 7, Issue 5, 2015, Pages 1-15

  Kim, Brian S ^a   Artis, David ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VERMES;

TRANSCRIPTION FACTOR;

CYTOLOGY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOID TISSUE; PHYSIOLOGY; SKIN;

HUMANS; IMMUNITY, INNATE; LYMPHOID TISSUE; SKIN; TRANSCRIPTION FACTORS;

EID: 84930454789     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016337     Document Type: Article

References (87)

1. Bando JK, Nussbaum JC, Liang HE, Locksley RM. 2013. Type 2 innate lymphoid cells constitutively express argi-nase-I in the na¨ıve and inflamed lung. J Leukoc Biol 94: 877–884.
2. Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, Bucks C, Wu X, Kane CM, Neill DR, et al. 2013. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 132: 933–941.
3. Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Ka-zani S, Wechsler ME, Israel E, Levy BD. 2013. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5: 174ra126.
4. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKen-zie AN, Kita H. 2012. IL-33–responsive lineage– CD25þ CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188: 1503–1513.
5. Beamer CA, Girtsman TA, Seaver BP, Finsaas KJ, Migliaccio CT, Perry VK, Rottman JB, Smith DE, HolianA. 2012. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 7: 1070–1081.
6. Bjorkstrom NK, Kekalainen E, Mjosberg J. 2013. Tissue-specific effector functions of innate lymphoid cells. Immunology 139: 416–427.
7. Blazquez AB, Mayer L, Berin MC. 2010. Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. Gastroenterology 139: 1301–1309.
8. Camelo A, Barlow JL, Drynan LF, Neill DR, Ballantyne SJ, Wong SH, Pannell R, Gao W, Wrigley K, Sprenkle J, et al. 2012. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13. J Gastroenterol 47: 1198–1211.
9. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12: 631–638.
10. Chang JE, Doherty TA, Baum R, Broide D. 2013. Prostaglan-din D2 regulates human type 2 innate lymphoid cell che-motaxis. J Allergy Clin Immunol 133: 899–901.
11. Chu DK, Llop-Guevara A, Walker TD, Flader K, Goncharo-va S, Boudreau JE, Moore CL, Seunghyun In T, Waser-man S, Coyle AJ, et al. 2013. IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization. J Allergy Clin Immunol 131: e181–188.
12. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A. 2014.Acommitted precursorto innatelymphoid cells. Nature 508: 397–401.
13. Corrigan CJ, Wang W, Meng Q, Fang C, Eid G, Caballero MR, Lv Z, An Y, Wang YH, Liu YJ, et al. 2011. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 128: 116–124.
14. Deleuran M, Hvid M, Kemp K, Christensen GB, Deleuran B, Vestergaard C. 2012. IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis. Chem Immunol Allergy 96: 45–49.
15. Doherty TA, Khorram N, Chang JE, Kim HK, Rosenthal P, Croft M, Broide DH. 2012. STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria. Am J Physiol Lung Cell Mol Physiol 303: L577–588.
16. Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. 2013. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates T2 cytokine production. J Allergy Clin Immunol 132: 205–213.
17. Fallon PG, Ballantyne SJ, Mangan NE, Barlow JL, Dasvarma A, Hewett DR, McIlgorm A, Jolin HE, McKenzie AN. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 203: 1105–1116.
18. Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, et al. 2001. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15: 985–995.
19. Fuchs A, Colonna M. 2013. Innate lymphoid cells in ho-meostasis, infection, chronic inflammation and tumors of the gastrointestinal tract. Curr Opin Gastroenterol 29: 581–587.
20. Gorski SA, Hahn YS, Braciale TJ. 2013. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog 9: e1003615.
21. Halim TY, Krauss RH, Sun AC, Takei F. 2012a. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36: 451–463.
22. Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM, Takei F. 2012b. Retinoic-acid-receptor-related orphan nuclear receptor a is required for natural helper cell development and allergic inflammation. Immunity 37: 463–474.
23. Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F. 2014. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40: 425–435.
24. Hams E, Locksley RM, McKenzie AN, Fallon PG. 2013. Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice. J Immunol 191: 5349–5353.
25. Hams E, Armstrong ME, Barlow JL, Saunders SP, Schwartz C, Cooke G, Fahy RJ, Crotty TB, Hirani N, Flynn RJ, et al. 2014. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci 111: 367–372.
26. Hepworth MR, Monticelli LA, Fung TC, Ziegler CG, Grun-berg S, Sinha R, Mantegazza AR, Ma HL, Crawford A, Angelosanto JM, et al. 2013. Innate lymphoid cells regulate CD4þ T-cell responses to intestinal commensal bacteria. Nature 498: 113–117.
27. Herberth G, Daegelmann C, Roder S, Behrendt H, Kramer U, Borte M, Heinrich J, Herbarth O, Lehmann I.2010. IL-17E but not IL-17A is associated with allergic sensitiza-tion: Results from the LISA study. Pediatr Allergy Immunol 21: 1086–1090.
28. Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M, Diefenbach A. 2012. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37: 634–648.
29. Hung LY, Lewkowich IP, Dawson LA, Downey J, Yang Y, Smith DE, Herbert DR. 2013. IL-33 drives biphasic IL-13 production for noncanonical type 2 immunity against hookworms. Proc Natl Acad Sci 110: 282–287.
30. Hvid M, Vestergaard C, Kemp K, Christensen GB, Deleuran B, Deleuran M. 2011. IL-25 in atopic dermatitis: A possible link between inflammation and skin barrier dysfunction? J Invest Dermatol 131: 150–157.
31. Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yo-shimoto T, Nakanishi K, Yamanishi K. 2013. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci 110: 13921–13926.
32. Kabata H, Moro K, Fukunaga K, Suzuki Y, Miyata J, Masaki K, Betsuyaku T, Koyasu S, Asano K. 2013. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat Com-mun 4: 2675.
33. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, Savage PB, McKenzie AN, Smith DE, Rottman JB, et al. 2012. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 129: 216–227.
34. Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D. 2013a. TSLPelicits IL-33-indepen-dent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5: 170ra116.
35. Kim BS, Wojno ED, Artis D. 2013b. Innate lymphoid cells and allergic inflammation. Curr Opin Immunol 25: 738–744.
36. Kleinjan A, Klein Wolterink RG, Levani Y, de Bruijn MJ, Hoogsteden HC, van Nimwegen M, Hendriks RW. 2014. Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice. J Immunol 192: 1385–1394.
37. Klein Wolterink RG, Kleinjan A, vanNimwegen M, Bergen I, de Bruijn M, Levani Y, Hendriks RW. 2012. Pulmonary innate lymphoid cells are major producersof IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42: 1106–1116.
38. Klein Wolterink RG, Serafini N, vanNimwegen M, Vosshen-rich CA, de Bruijn MJ, Fonseca Pereira D, Veiga Fer-nandes H, Hendriks RW, Di Santo JP. 2013. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5þ and IL-13þ type 2 innate lymphoid cells. Proc Natl Acad Sci 110: 10240–10245.
39. Klose CS, Flach M, Mohle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D, et al. 2014. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157: 340–356.
40. Kwon BI, Hong S, Shin K, Choi EH, Hwang JJ, Lee SH. 2013. Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax. Am J Respir Crit Care Med 188: 577–585.
41. Liang Y, Jie Z, Hou L, Aguilar-Valenzuela R, Vu D, Soong L, Sun J. 2013. IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J Immunol 190: 5666–5675.
42. Licona-Limon P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Limon I, Ishigame H, Hao L, Herbert DR, Flavell RA. 2013. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity 39: 744–757.
43. Maarsingh H, Zaagsma J, Meurs H. 2009. Arginase: A key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol 158: 652–664.
44. McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, Voehringer D, McKenzie AN, Neurath MF, Pflanz S, et al. 2013. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39: 357–371.
45. Meylan F, Hawley ET, Barron L, Barlow JL, Penumetcha P, Pelletier M, Sciume G, Richard AC, Hayes ET, Gomez-Rodriguez J, et al. 2014. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol 7: 958–968.
46. Miller AM, Asquith DL, Hueber AJ, Anderson LA, Holmes WM, McKenzie AN, Xu D, Sattar N, McInnes IB, Liew FY. 2010. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 107: 650–658.
47. Mirchandani AS, Besnard AG, Yip E, Scott C, Bain CC, Cerovic V, Salmond RJ, Liew FY. 2014. Type 2 innate lymphoid cells drive CD4þ Th2 cell responses. J Immunol 192: 2442–2448.
48. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. 2011. Human IL-25- and IL-33-responsive type 2 innate lym-phoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12: 1055–1062.
49. Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H. 2012. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37: 649–659.
50. Molofsky AB, Nussbaum JC, Liang HE, Van Dyken SJ, Cheng LE, Mohapatra A, Chawla A, Locksley RM. 2013. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated mac-rophages. J Exp Med 210: 535–549.
51. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12: 1045–1054.
52. Monticelli LA, Sonnenberg GF, Artis D. 2012. Innate lym-phoid cells: Critical regulators of allergic inflammation and tissue repair in the lung. Curr Opin Immunol 24: 284–289.
53. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S. 2010. Innate production of TH2 cytokines by adipose tissue- associated c-KitþSca-1þ lymphoid cells. Nature 463: 540–544.
54. Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, Suh LA, Norton J, Harris KE, Grammer LC, et al. 2013. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosi-nusitis. J Allergy Clin Immunol 132: 593–600.
55. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367–1370.
56. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang HE, et al. 2013. Type 2 innate lym-phoid cells control eosinophil homeostasis. Nature 502: 245–248.
57. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA. 2009. Arginase-1–expressing mac-rophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
58. Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. 2010. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 125: 752–754.
59. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM. 2010. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci 107: 11489–11494.
60. Qiu J, Guo X, Chen ZM, He L, Sonnenberg GF, Artis D, Fu YX, Zhou L. 2013. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of micro-flora. Immunity 39: 386–399.
61. Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, Mitchell AJ, Tay SS, Jain R, Forbes-Blom E, et al. 2013. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 14: 564–573.
62. Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF Jr, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T, et al. 2010. IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses. Nature 464: 1362–1366.
63. Saenz SA, Siracusa MC, Monticelli LA, Ziegler CG, Kim BS, Brestoff JR, Peterson LW, Wherry EJ, Goldrath AW, Bhan-doola A, et al. 2013. IL-25 simultaneously elicits distinct populations of innate lymphoid cells and multipotent progenitor type 2 (MPPtype2) cells. J Exp Med 210: 1823–1837.
64. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN, et al. 2013. A role for IL-25 and IL-33-driven type-2 innate lymphoid cellsin atopic dermatitis. J Exp Med 210: 2939–2950.
65. Salmond RJ, Mirchandani AS, Besnard AG, Bain CC, Thomson NC, Liew FY. 2012. IL-33 induces innate lym-phoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J Allergy Clin Immunol 130: e1156.
66. Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich CA, Di Santo JP. 2010. IL-7 and IL-15 independently program the differentiation of intestinal CD3–NKp46þ cell subsets from Id2-dependent precursors. J Exp Med 207: 273–280.
67. Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimaki S, Karisola P, Reunala T, Wolff H, Lauerma A, et al. 2012. IL-33 and ST2 in atopic dermatitis: Expression profiles and modulation by triggering factors. J Invest Dermatol 132: 1392–1400.
68. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McCla-nahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479–490.
69. Shaw JL, Fakhri S, Citardi MJ, Porter PC, Corry DB, Kher-admand F, Liu YJ, Luong A. 2013. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Resp Crit Care Med 188: 432–439.
70. Shikotra A, Choy DF, Ohri CM, Doran E, Butler C, Harga-don B, Shelley M, Abbas AR, Austin CD, Jackman J, et al. 2012. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol 129: e101–109.
71. Sonnenberg GF. 2013. Editorial: New tricks for innate lym-phoid cells. J Leukocyte Biol 94: 862–864.
72. Sonnenberg GF, Artis D. 2012. Innate lymphoid cell interactions with microbiota: Implications for intestinal health and disease. Immunity 37: 601–610.
73. Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hut-nick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, et al. 2012. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336: 1321–1325.
74. Sonnenberg GF, Mjosberg J, Spits H, Artis D. 2013. SnapShot: Innate lymphoid cells. Immunity 39: 622–622.
75. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Hom-ey B, Gilliet M, Ho S, Antonenko S, Lauerma A, et al. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673–680.
76. Spits H, Cupedo T. 2012. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30: 647–675.
77. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, et al. 2013. Innate lymphoid cells—A proposal for uniform nomenclature. Nat Rev Immunol 13: 145–149.
78. Tait Wojno ED, Artis D. 2012. Innate lymphoid cells: Balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12: 445–457.
79. Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, Panzer U, Helmby H, Stockinger B. 2013. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210: 2951–2965.
80. Walker JA, Barlow JL, McKenzie AN. 2013. Innate lymphoid cells—How did we miss them? Nat Rev Immunol 13: 75–87.
81. Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B. 2011. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12: 1071–1077.
82. Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, et al. 2012. Transcription factor RORa is critical for nuocyte development. Nat Immunol 13: 229–236.
83. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Joui-han HA, Bando JK, Chawla A, Locksley RM. 2011. Eosinophils sustain adipose alternatively activated mac-rophages associated with glucose homeostasis. Science 332: 243–247.
84. Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H, Klenerman P, Ogg G. 2013. Prostaglandin D activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on T2 cells. J Allergy Clin Immunol 133: 1184–1194.
85. Yang Q, Monticelli LA, Saenz SA, Chi AW, Sonnenberg GF, Tang J, De Obaldia ME, Bailis W, Bryson JL, Toscano K, et al. 2013. T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38: 694–704.
86. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishi-kawa S, Gruss P. 1999. Development of peripheral lym-phoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702–706.
87. Yu X, Pappu R, Ramirez-Carrozzi V, Ota N, Caplazi P, Zhang J, Yan D, Xu M, Lee WP, Grogan JL. 2013. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 7: 730–740.